Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of resistance to bruton's tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. | Ann Hematol | 2026 | 41721839 | PubTator, text mining | PubMed |
| Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments. | Future Sci OA | 2026 | 41721713 | PubTator, text mining | PubMed |
| Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disorders. | EBioMedicine | 2026 | 41719795 | PubTator, text mining | PubMed |
| E-Cadherin Immunohistochemical Expression in Gastrointestinal Adenocarcinomas and Its Association With Histological and Prognostic Parameters. | Cureus | 2026 | 41710815 | PubTator, text mining | PubMed |
| Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis. | Front Med (Lausanne) | 2026 | 41704697 | PubTator, text mining | PubMed |
| C-terminus CD28 phosphorylation (Y218) modulates IL-2 secretion and antitumor effect of CAR-T cells. | bioRxiv | 2026 | 41659581 | PubTator, text mining | PubMed |
| [Multifocal EBV-associated smooth muscle tumors: a clinicopathological analysis of seven cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41644427 | PubTator, text mining | PubMed |
| Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor. | Nat Commun | 2026 | 41639073 | PubTator, text mining | PubMed |
| A case report of hemophagocytic lymphohistiocytosis occurring during ibrutinib chemotherapy with a literature review. | Medicine (Baltimore) | 2026 | 41559979 | PubTator, text mining | PubMed |
| Comparison of Three Automated Measurements of Ventricular Volumes of the Brain. | J Imaging Inform Med | 2026 | 41559506 | PubTator, text mining | PubMed |
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial. | JMIR Res Protoc | 2026 | 41558017 | PubTator, text mining | PubMed |
| SH2scan: Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders. | J Med Chem | 2026 | 41543922 | PubTator, text mining | PubMed |
| The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalk. | J Mol Med (Berl) | 2026 | 41483156 | PubTator, text mining | PubMed |
| Phosphoproteomic analysis of successive Jurkat CD19-CAR generations reveals TCRζ-driven signalling. | Cell Signal | 2026 | 41177417 | PubTator, text mining | PubMed |
| Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome. | Turk J Gastroenterol | 2025 | 41866875 | PubTator, text mining | PubMed |
| Integrative Machine Learning and Network Analysis of Skeletal Muscle Transcriptomes Identifies Candidate Pioglitazone-Responsive Biomarkers in Polycystic Ovary Syndrome. | Genes (Basel) | 2025 | 41595448 | PubTator, text mining | PubMed |
| Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors. | Front Pharmacol | 2025 | 41567642 | PubTator, text mining | PubMed |
| Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma. | Medicine (Baltimore) | 2025 | 41398767 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. | RSC Adv | 2025 | 41356712 | PubTator, text mining | PubMed |
| Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing. | PLoS One | 2025 | 41343465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=3